Blog
RSS FeedPosted by Michael Wonder on 30 Sep 2023
Schedule of Pharmaceutical Benefits - 1 October 2023
1 October 2023 - The October 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 27 Sep 2023
Agenda for November 2023 PBAC meeting – 25 September 2023 update
27 September 2023 - The agenda for the November 2023 meeting has been updated yet again. ...
Posted by Michael Wonder on 27 Sep 2023
Expanded medicines for breast cancer and leukaemia on the PBS
26 September 2023 - From 1 September 2023, Australians with an aggressive form of breast cancer and certain types of leukaemia ...
Posted by Michael Wonder on 26 Sep 2023
Updates to the HTA Policy and Methods Review Reference Committee – 26 September 2023
26 September 2023 - The agenda for this week's HTA Review Reference Committee meeting is now available. ...
Posted by Michael Wonder on 21 Sep 2023
Updates to the Health Technology Assessment Policy and Methods Review Reference Committee – 22 September 2023
21 September 2023 - The agenda for this week's HTA Review Reference Committee meeting is now available. ...
Posted by Michael Wonder on 18 Sep 2023
New form of fast-acting insulin added to the PBS
18 September 2023 - The Albanese Government is listing a new form of fast-acting insulin on the PBS from 1 ...
Posted by Michael Wonder on 14 Sep 2023
Here we go again - version 4
14 September 2023 - The Department has today published version 4 of the agenda for the November 2023 PBAC meeting. ...
Posted by Michael Wonder on 11 Sep 2023
More insights from the agenda for November 2023 PBAC meeting
12 September 2023 - One wonders how many people actually examine the agenda closely. We can see two minor issues ...
Posted by Michael Wonder on 08 Sep 2023
Review of cancer related surrogate outcomes used for PBAC decision-making
8 September 2023 - Surrogate outcome measures have an increasingly important role in cancer medicine research providing evidence to support ...
Posted by Michael Wonder on 05 Sep 2023
Mum vows to keep pushing for fenfluramine PBS listing for Dravet syndrome, a severe form of epilepsy
5 September 2023 - Families calling for greater access to a medication that helps manage a severe form of epilepsy ...
Posted by Michael Wonder on 01 Sep 2023
Department publishes revised agenda for November 2023 PBAC meeting
1 September 2023 - The initial agenda for the November 2023 PBAC meeting has been updated. ...
Posted by Michael Wonder on 01 Sep 2023
Pharmacy Guild suspends campaign as 60 day dispensing begins
1 September 2023 - The Pharmacy Guild of Australia has agreed to suspend its campaign against 60 day dispensing after ...
Posted by Michael Wonder on 01 Sep 2023
Department publishes revised agenda for the September 2023 PBAC meeting
31 August 2023 - The agenda for this month's intracycle meeting has been updated. ...
Posted by Michael Wonder on 31 Aug 2023
Schedule of Pharmaceutical Benefits - 1 September 2023
1 September 2023 - The September 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 29 Aug 2023
Australia knocks back application for diabetes drug that could overshadow Ozempic
29 August 2023 - Australia has knocked back an application to subsidise the diabetes drug Mounjaro but the manufacturer still wants ...